Bliss GVS Pharma

{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "493.65",
    "chg": -3.35,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "497.00",
    "mcapval": "5,365.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Aug 06, 03:30 PM",
    "curr_time": "19:54 PM",
    "last_traded_at": "Aug 06, 03:30 PM IST",
    "bse_nse_vol": "2.09 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 06, 2026",
    "traded_date_str": "2026 08 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4137019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4137019.png",
        "date": "2026-08-05 08:04:21",
        "description": "Bliss GVS Pharma Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by robust signals across multiple indicators including MACD, Bollinger Bands, and moving averages. This technical evolution coincides with a strong price performance that outpaces the broader Sensex, signalling renewed investor confidence in this small-cap pharmaceutical player."
      },
      {
        "title": "Bliss GVS Pharma Ltd Locks at Upper Circuit With 4.41% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-upper-circuit-amid-strong-buying-pressure-4135580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_stocks_hitting_upper_circuit_4135580.png",
        "date": "2026-08-04 11:00:14",
        "description": "At Rs 489.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 4.41% on 4 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4134887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4134887.png",
        "date": "2026-08-04 08:06:44",
        "description": "Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early August 2026. Despite a slight dip in daily price, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, and moving averages suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4132913",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4132913.png",
        "date": "2026-08-03 08:02:05",
        "description": "Bliss GVS Pharma Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by strong weekly and monthly MACD signals and daily moving averages, the pharmaceutical small-cap is demonstrating renewed investor interest despite mixed short-term returns compared to the broader Sensex."
      },
      {
        "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4129528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_technicaldot_4129528.png",
        "date": "2026-07-31 08:01:46",
        "description": "Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, key indicators such as MACD and KST maintain bullish signals on weekly and monthly charts, while moving averages and Bollinger Bands suggest cautious optimism. This article analyses the evolving technical landscape of this small-cap pharmaceutical stock, contextualising its performance against broader market trends and providing a comprehensive view for investors."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-4124240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_mojoScore_4124240.png",
        "date": "2026-07-28 10:10:03",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Bliss GVS Pharma Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-surges-to-upper-circuit-on-strong-buying-momentum-4117910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_stocks_hitting_upper_circuit_4117910.png",
        "date": "2026-07-23 12:00:11",
        "description": "At Rs 470.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 5.0% on 23 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Below All Moving Averages and Now at Lower Circuit: Bliss GVS Pharma Ltd Loses 4.94% in a Single Session",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4106497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_stocks_hitting_lower_circuit_4106497.png",
        "date": "2026-07-17 13:00:09",
        "description": "At Rs 480, sellers were still queuing — but there were no buyers willing to take the other side. Bliss GVS Pharma Ltd locked at its lower circuit of 4.94% on 17 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-4106341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_mojoScore_4106341.png",
        "date": "2026-07-17 10:10:04",
        "description": "Bliss GVS Pharma Ltd is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred over seven months ago, the analysis and financial metrics presented here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 400,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled \"we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.\".",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Press Release",
      "datetime": "09-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Jul 26",
          "dt": "2026-07-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-08-05 08:04:21

Bliss GVS Pharma Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by robust signals across multiple indicators including MACD, Bollinger Bands, and moving averages. This technical evolution coincides with a strong price performance that outpaces the broader Sensex, signalling renewed investor confidence in this small-cap pharmaceutical player.

Read full news article

Bliss GVS Pharma Ltd Locks at Upper Circuit With 4.41% Gain — Buyers Queue, Sellers Absent

2026-08-04 11:00:14

At Rs 489.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 4.41% on 4 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-04 08:06:44

Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early August 2026. Despite a slight dip in daily price, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, and moving averages suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-03 08:02:05

Bliss GVS Pharma Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by strong weekly and monthly MACD signals and daily moving averages, the pharmaceutical small-cap is demonstrating renewed investor interest despite mixed short-term returns compared to the broader Sensex.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-31 08:01:46

Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, key indicators such as MACD and KST maintain bullish signals on weekly and monthly charts, while moving averages and Bollinger Bands suggest cautious optimism. This article analyses the evolving technical landscape of this small-cap pharmaceutical stock, contextualising its performance against broader market trends and providing a comprehensive view for investors.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-07-28 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

Bliss GVS Pharma Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-07-23 12:00:11

At Rs 470.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 5.0% on 23 Jul 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Below All Moving Averages and Now at Lower Circuit: Bliss GVS Pharma Ltd Loses 4.94% in a Single Session

2026-07-17 13:00:09

At Rs 480, sellers were still queuing — but there were no buyers willing to take the other side. Bliss GVS Pharma Ltd locked at its lower circuit of 4.94% on 17 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-07-17 10:10:04

Bliss GVS Pharma Ltd is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred over seven months ago, the analysis and financial metrics presented here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

View All News